AnaptysBio, Inc. (ANAB)
51.34
+0.97
(+1.93%)
USD |
NASDAQ |
Jun 08, 16:00
51.00
-0.34
(-0.66%)
After-Hours: 18:52
AnaptysBio Total Liabilities (Quarterly) : 316.94M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 414.44M |
| Vanda Pharmaceuticals, Inc. | 152.76M |
| Precision BioSciences, Inc. | 67.79M |
| Amgen, Inc. | 83.31B |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 329.68M |
| Shareholders Equity (Quarterly) | 12.75M |
| Debt to Equity Ratio | 21.76 |
| Current Ratio | 7.580 |
| Net Debt Paydown Yield | 1.72% |